FIELD: medicine.SUBSTANCE: invention refers to medicine namely to neurosurgery resuscitation and neurology and may be used for treating the permanent unconscious vegetative state. That is ensured by intratympanic streptomycin treatment with underlying common drug therapy of the state. The completion of the above is followed by the electric transcranial exposure on the brain. For the intratympanic treatment streptomycin 1 g is dissolved in physiologic saline 1 ml. The preparation is introduced on...

PURPOSE: A pharmaceutical composition containing cilostazol and a ginkgo leaf extract for preventing or treating hearing loss is provided to suppress apoptosis of auditory cells caused by generation of reactive oxygen species (ROS) thereby effectively preventing or treating noise deafness or ototoxic deafness. CONSTITUTION: A pharmaceutical composition for preventing or treating hearing loss contains cilostazol and a gingko leaf extract as active ingredients which are mixed in a weight ratio of ...

FIELD: medicine pharmaceutics.SUBSTANCE: invention refers to veterinary microbiology immunology biotechnology namely to technology of an antigen for diagnosing brucellosis. The method for producing brucellous L-antigen is implemented as follows. The strain Brucella abortus 19 is cultured in the L-form on a solid nutrient medium prepared of meat-peptone liver glucose-glycerol agar (1.3-1.5% agar) with added 10-15% normal horse serum and streptomycin in a dose of 2.5-5.0 Units/ml at 37-38°C for 4-...